![]() | |||||
disease | |||||
新闻 | |||||
What the latest science says about Lyme disease - The Washington Post Lyme disease is a bacterial infection that spreads through tick bites. It may cause flu-like symptoms and a bull's-eye-shaped rash. Most people fully ...
| |||||
Johnson & Johnson's nipocalimab shows promise in Sjögren's disease trial Johnson & Johnson has announced findings from the Phase II DAHLIAS dose-ranging study of nipocalimab in Sjögren's disease patients.
| |||||
Trachoma: how a common cause of blindness can be prevented worldwide Trachoma is an eye disease caused by specific strains of the bacterium Chlamydia trachomatis. These bacteria are infectious and can spread between ...
| |||||
Ismidenon by AmyriAD Therapeutics for Alzheimer's Disease: Likelihood of Approval ... Disease. According to GlobalData, Phase II drugs for Alzheimer's Disease have a 36% phase transition success rate (PTSR) indication benchmark for ...
| |||||
Alzheimer's Disease Pipeline Landscape 2024: Comprehensive Insights About 110+ ... Currently the drug is in Phase II stage of Clinical trial evaluation for the treatment of Alzheimer's disease. CT1812: Cognition Therapeutics
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
![]() |
发送反馈 |
No comments:
Post a Comment